Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Study Identifier
191622-147
CT.gov Identifier
NCT02248844
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Facial Aesthetics - Toxins
    • Study Drug
  • Botulinum Toxin Type A
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 75 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Subject and Investigator decision to treat crow's feet lines with Botox®
    Exclusion Criteria:
    * None

    Protocol Summary

    This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.

    Study Locations

    Location
    Status
    Location
    Dr. Robbin Clinic
    Gangnam-gu, Seoul, Republic of Korea, 135-839
    Status
    Not applicable